The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,855,417 in first-year total cost, median $995,029.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-J (51)]3
Most frequent institutions
- PATH1
- RESEARCH TRIANGLE INSTITUTE1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | NextGen Long-acting and targeted combination ART for Children with HIV1R61AI149665-01 | HO, RODNEY J.Y.MELVIN, ANN JORNS | UNIVERSITY OF WASHINGTON, WA | $1,026,862 | ZRG1 |
| 2020 | LA HIV Treatment in Pediatrics1R61AI149499-01 | COTTRELL, MACKENZIEJOHNSON, LEAH | RESEARCH TRIANGLE INSTITUTE, NC | $995,029 | ZRG1 |
| 2020 | MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV Infection1R61AI149642-01 | DONNELLY, RYANZEHRUNG, DARIN | PATH, WA | $833,526 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.